clofarabine (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the clofarabine drug offered from sanofi-aventis U.S. LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | clofarabine |
| SUBSTANCE NAME: | CLOFARABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2017-05-11 |
| END MARKETING DATE: | 0000-00-00 |
clofarabine HUMAN PRESCRIPTION DRUG Details:
| Item Description | clofarabine from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2017-05-11 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0955-1746_d5edb873-461d-47ce-8337-ce24d6151828 |
| PRODUCT NDC: | 0955-1746 |
| APPLICATION NUMBER: | NDA021673 |
Other CLOFARABINE Pharmaceutical Manufacturers / Labelers:
